Literature DB >> 10718174

Quality of life in patients with early and advanced carcinoma of the breast.

M Pandey1, S P Singh, P B Behere, S K Roy, S Singh, V K Shukla.   

Abstract

AIM: Emotional disturbances are known to occur in patients suffering from malignant diseases even after treatment. This is mainly because of a fear of death which modifies quality of life (QOL). QOL has gained an important place in the management of cancer in industrialized nations, with the increase in survival. However, in developing countries like India, very little attention has been paid to this issue. Developing countries have poor infrastructure and lack proper treatment facilities at most centres, this leads to poor survival rates and hence much emphasis is on attaining quantity of life rather than quality. This study was carried out to assess the quality of life determinant in patients with breast cancer and the impact of treatment on quality of life indices.
METHODS: We carried out QOL assessment in 50 patients with breast cancer using the modified linear analogue scale for self assessment (LASA).
RESULTS: Significant deterioration was seen in health-related parameters in terms of recreation (P=0.01), social life (P=0.002), mobility (P=0.03), physical activity (P=0.4) and sleep and appetite (P=0.05). Treatment related parameters deteriorated in both early and advanced carcinoma. Similarly, weight loss was seen in both the groups, however, this was not statistically significant. Self-care and recreation were found to be the most important parameters influencing the QOL in breast cancer patients.
CONCLUSIONS: Breast cancer detection programs, health education and better awareness among women in industrialized nations has helped in downstaging of the disease, thus improving overall survival. It has not been so in developing countries, where the majority of patients present with advanced disease (T3 and T4). These are usually managed with surgery and adjuvant chemotherapy, which duly interferes with general health-related parameters and the social life of these patients, thereby adversely affecting the QOL.

Entities:  

Mesh:

Year:  2000        PMID: 10718174     DOI: 10.1053/ejso.1999.0734

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

1.  Quality of life in breast cancer patients: validation of a FACT-B Malayalam version.

Authors:  M Pandey; B C Thomas; K Ramdas; S Eremenco; M K Nair
Journal:  Qual Life Res       Date:  2002-03       Impact factor: 4.147

2.  Psychological responses to cancer recurrence.

Authors:  Barbara L Andersen; Charles L Shapiro; William B Farrar; Timothy Crespin; Sharla Wells-Digregorio
Journal:  Cancer       Date:  2005-10-01       Impact factor: 6.860

3.  Development and validation of an instrument to measure the effects of a mistletoe preparation on quality of life of cancer patients: the Life Quality Lectin-53 (LQL-53) Questionnaire.

Authors:  Inge Kirchberger; Dieter Wetzel; Thomas Finger
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

4.  FACT-G: reliability and validity of the Malayalam translation.

Authors:  B C Thomas; M Pandey; K Ramdas; P Sebastian; M K Nair
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

5.  Quality of life determinants in women with breast cancer undergoing treatment with curative intent.

Authors:  Manoj Pandey; Bejoy Cherian Thomas; Padmakumar SreeRekha; Kunnambath Ramdas; Kuttan Ratheesan; Sankarannair Parameswaran; Beela S Mathew; Balakrishnan Rajan
Journal:  World J Surg Oncol       Date:  2005-09-27       Impact factor: 2.754

6.  International phase 1 study protocol to develop a health state classification system for a preference-based measure for women with breast cancer: the BREAST-Q Utility module.

Authors:  Manraj Kaur; Andrea L Pusic; Stefan J Cano; Feng Xie; Louise Bordeleau; Toni Zhong; Anne Klassen
Journal:  BMJ Open       Date:  2020-01-07       Impact factor: 2.692

7.  Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000.

Authors:  Kenji Shibuya; Colin D Mathers; Cynthia Boschi-Pinto; Alan D Lopez; Christopher J L Murray
Journal:  BMC Cancer       Date:  2002-12-26       Impact factor: 4.430

8.  Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment.

Authors:  Stéphanie Boini; Serge Briançon; Francis Guillemin; Pilar Galan; Serge Hercberg
Journal:  Health Qual Life Outcomes       Date:  2004-01-09       Impact factor: 3.186

Review 9.  Quality of life in Arab women with breast cancer: a review of the literature.

Authors:  Bouchra Haddou Rahou; Karima El Rhazi; Fatima Ouasmani; Chakib Nejjari; Rachid Bekkali; Ali Montazeri; Abdelhalem Mesfioui
Journal:  Health Qual Life Outcomes       Date:  2016-04-27       Impact factor: 3.186

10.  Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice.

Authors:  Krzysztof Adamowicz; Zuzanna Baczkowska-Waliszewska
Journal:  Health Qual Life Outcomes       Date:  2020-05-12       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.